Home
Conference Homepage
Program
FAQs
Contact
Forgot your
password?
Login
Close
Attendee search
Organisations
Attendees
Print
Groups
All
Plenary speakers
Presenting companies
Sponsors
Keywords
allergy
autoimmune
big pharma
biologics
CNS
diagnostics
drug delivery
fund
government agency
in-licensing
infectious diseases
inflammation
intellectual property
international trade
investor
inward investment
medical devices
neuroscience
oncology
out-licensing
peptides
phase 1
phase 2
phase 3
preclinical
targets
therapeutic antibodies
topical
vaccines
venture capital
Index
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
All
Countries
All
Austria
Canada
Denmark
Finland
France
Germany
Ireland
Netherlands
Norway
Spain
Sweden
Switzerland
United Kingdom
United States
Reset
Order alphabetically
Order by date approved
Erik Van den Berg
AM-Pharma B.V.
Chief Executive Officer
Willem van Weperen
To-BBB Technologies BV
CEO
Esteban Pombo Villar
Oxford BioTherapeutics AG
Chief Operating Officer
Powered by Meeting MojoTM 